The US Oncology Network

Latest from The US Oncology Network

Dr. Monk on the Significance of Bevacizumab in Cervical Cancer

May 08, 2020

Video

Bradley J. Monk, MD, FACS, FACOG, discusses the FDA approval of bevacizumab and other novel agents in cervical cancer.

Dr. Coleman on Recent Advances and Remaining Questions in Ovarian Cancer

May 05, 2020

Video

Robert L. Coleman, MD, FACOG, FACS, discusses recent advances made in the treatment of patients with ovarian cancer and remaining questions regarding the role of immunotherapy.

Brentuximab Vedotin Plus Nivolumab Impresses in Older Patients With Hodgkin Lymphoma

April 24, 2020

Article

Christopher A. Yasenchak, MD, discusses findings from the phase 2 trial with brentuximab vedotin and nivolumab in patients with newly diagnosed classical Hodgkin lymphoma.

The US Oncology Network Names Renowned Cancer Researcher Robert L. Coleman, MD, Chief Scientific Officer

April 07, 2020

Article

The US Oncology Network (The Network) has named prominent cancer researcher Robert L. Coleman, MD, FACOG, FACS, as its new Chief Scientific Officer.

Dr. Denduluri on Treatment Approaches in Early-Stage HR+/HER2- Breast Cancer

April 07, 2020

Video

Neelima Denduluri, MD, shares treatment approaches in patients with early-stage hormone receptor-positive, HER2-negative breast cancer.

Dr. Sharman on Remaining Challenges With BTK Inhibitors in CLL

February 07, 2020

Video

Jeff Sharman, MD, discusses the question of BTK inhibitors in treating patients with chronic lymphocytic leukemia.